Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Emergent BioSolutions
AddedMar 19, 2024
UpdatedJul 3, 2026
Emergent BioSolutions

Emergent BioSolutions

Public

American biopharmaceutical company developing vaccines and therapeutics in Gaithersburg, MD.

HQ
Gaithersburg, MD, US
Founded
1998
Overview
Compare
Fundraising
Employees
Website

Emergent BioSolutions Inc., founded on September 5, 1998, by Fuad El-Hibri, is a biopharmaceutical company headquartered in Gaithersburg, Maryland. The company's core mission is to provide preparedness and response solutions for public health threats (PHTs), including chemical, biological, radiological, nuclear, and explosive threats, as well as emerging infectious diseases and public health crises. Emergent BioSolutions offers products such as the ACAM2000 smallpox vaccine and Anthrasil, among others, focusing on acute, emergency, and community care.

Notable affiliated individuals include interim CEO Haywood Miller. The company is publicly traded on the NYSE under the ticker EBS and is a component of the Russell 2000 index. Key achievements include the development and provision of critical vaccines and therapeutics that address significant public health threats. Emergent BioSolutions has made a substantial impact on public health preparedness and response, contributing to national and global health security.

Emergent BioSolutions - Similar Companies

Emergo Therapeutics logo

Emergo Therapeutics

Novavax logo

Novavax

novavax.com

IBT Vaccines logo

IBT Vaccines

Moderna logo

Moderna

modernatx.com

AmplifyBio logo

AmplifyBio

Globavir Biosciences logo

Globavir Biosciences

Coalition for Epidemic Preparedness Innovations logo

Coalition for Epidemic Preparedness Innovations

cepi.net

Mapp Biopharmaceutical logo

Mapp Biopharmaceutical

mappbio.com

GeoVax Labs logo

GeoVax Labs

geovax.com

Flugen logo

Flugen

Gilead Sciences logo

Gilead Sciences

gilead.com

Chimerix logo

Chimerix

Centivax logo

Centivax

centivax.com

Epivax logo

Epivax

epivax.com

Soligenix logo

Soligenix

Emergent BioSolutions - Quick Facts

Who are Emergent BioSolutions' competitors?

Companies similar to Emergent BioSolutions include Emergo Therapeutics, Novavax, IBT Vaccines and Moderna.

When was Emergent BioSolutions founded?

Emergent BioSolutions was founded in 1998.

Where is Emergent BioSolutions' headquarters located?

Emergent BioSolutions' headquarters is located in Gaithersburg, MD, US.

How much has Emergent BioSolutions raised to-date?

As of Nov 14, 2022, Emergent BioSolutions has raised a total of $36.5M (USD).

How many employees does Emergent BioSolutions have?

Emergent BioSolutions has 2,500 employees as of Feb 6, 2024.

Emergent BioSolutions - Classification

Ownership
  • Public
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
Customer
  • Enterprise
  • Government
Main Product
  • Therapeutics
  • Vaccines
Tags
  • Biopharmaceutical
  • Biotech
  • Healthtech
Unique IDs
  • ein: 141902018
  • secCik: 0001367644
  • ticker: EBS
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 621000Ambulatory Health Care Services
  • 621500Medical and Diagnostic Laboratories
  • 621510Medical and Diagnostic Laboratories
  • 621511Medical Laboratories
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8070Medical And Dental Laboratories
  • 8071Medical Laboratories
  • 2800Chemicals And Allied Products
  • 2830Drugs
  • 2834Pharmaceutical Preparations
ISIC
  • 2100Manufacture of pharmaceuticals, medicinal chemical and botanical products
Show 24 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325414Biological Product (except Diagnostic) Manufacturing
  • 339100Medical Equipment and Supplies Manufacturing
  • 339110Medical Equipment and Supplies Manufacturing
  • 339112Surgical and Medical Instrument Manufacturing
  • 330000Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 339000Miscellaneous Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2836Biological Products, Except Diagnostic Substances
  • 3840Surgical, Medical, And Dental Instruments And Supplies
  • 3841Surgical And Medical Instruments And Apparatus
  • 4000Railroad Transportation
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research
ISIC
  • 3250Manufacture of medical and dental instruments and supplies